Ministry of Health, Labour and Welfare (MHLW), with the Pharmaceuticals and Medical Devices Agency (PMDA) doing the scientific review and safety monitoring
Is Liraglutide legal in Japan?
The regulator has approved it as a medicine.
PMDA lists Victoza (type 2 diabetes, 20 January 2010) and the insulin degludec plus liraglutide combination Xultophy (18 June 2019). PMDA's package-insert database returns only these two liraglutide products, and none is for obesity. On the NHI price list applicable from 13 August 2026, Victoza carries a transitional-use deadline of 31 March 2027, which normally signals that the product is being removed from the list, while the Xultophy combination remains listed. Generic liraglutide is not shown on the lists we checked.
Last verified 2026-09-29 · how we verify
Liraglutide elsewhere
Sources (3)
- 01List of Approved Drugs, April 2004 to February 2026 (new drugs)Pharmaceuticals and Medical Devices Agency (PMDA) · 2026 · accessed 2026-09-29
- 02Prescription drug package insert and review report search (医療用医薬品 添付文書等情報検索)Pharmaceuticals and Medical Devices Agency (PMDA) · 2026-09-29 · accessed 2026-09-29
- 03NHI drug price list and generic drug information, applicable from 13 August 2026 (薬価基準収載品目リスト)Ministry of Health, Labour and Welfare (MHLW) · 2026-08-13 · accessed 2026-09-29